Target intelligence / Profile preview

Arginine-glutamic acid dipeptide repeats pseudogene 2 Y-linked (REREP2Y)

Target
REREP2Y
Molecular classification
Other (pseudogene)
01

Overview

"Arginine-glutamic acid dipeptide repeats pseudogene 2 Y-linked" (REREP2Y) does not correspond to a recognized gene, protein, or therapeutic target in major reference resources. Based on its name, it is classified as a pseudogene located on the Y chromosome that encodes sequences similar to arginine-glutamic acid dipeptide repeats. Pseudogenes are non-functional sequences of genomic DNA originally derived from functional genes but rendered inactive through mutation, deletion, or genomic rearrangement. While pseudogenes can sometimes regulate parental gene expression via RNA-mediated mechanisms, there is no evidence REREP2Y has any known biological activity, disease involvement, or pharmacological relevance[1][2][3]. This entry likely reflects a non-standard, hypothetical, or artifact designation rather than an established molecular target. The use of "pseudogene" in the name signifies it is not a protein-coding gene, functional receptor, enzyme, or drug target. If precise information is needed for biomedical applications, this entity should not be considered a valid molecular target.

02

Mechanism of action

Not applicable (not a therapeutic target)

03

Biological functions

Pseudogenes as a class may have potential roles in RNA-level gene regulation (such as acting as decoys for microRNAs or generating regulatory RNAs), but no function is attributed specifically to REREP2Y
04

Disease associations

No disease associations are reported. For other pseudogenes, altered expression can sometimes influence cancer or other diseases, but this is not established for REREP2Y.

Beyond the preview

Go deeper on Arginine-glutamic acid dipeptide repeats pseudogene 2 Y-linked (REREP2Y).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arginine-glutamic acid dipeptide repeats pseudogene 2 Y-linked (REREP2Y).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call